Detection of mutations in myeloid malignancies through paired-sample analysis of Microdroplet-PCR deep sequencing data

Journal of Molecular Diagnostics

Volumn 16, Issue 5, 2014, Pages 504-518

  Cheng, Donavan T ^a   Cheng, Janice ^a   Mitchell, Talia N ^a   Syed, Aijazuddin ^a   Zehir, Ahmet ^a   Mensah, Nana Yaa T ^a   Oultache, Alifya ^a   Nafa, Khedoudja ^a   Levine, Ross L ^a   Arcila, Maria E ^a   Berger, Michael F ^a   Hedvat, Cyrus V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; DNA METHYLTRANSFERASE 3A; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; JANUS KINASE 2; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALGORITHM; AMPLICON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BASE COMPOSITION; EXON; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE MAP; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; INDEL MUTATION; MICRODROPLET POLYMERASE CHAIN REACTION DEEP SEQUENCING; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; MYELOPROLIFERATIVE NEOPLASM; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BONE MARROW CELL; GENETIC SCREENING; GENETICS; LEUKEMIA, MYELOID; METABOLISM; MUTATION; MYELOPROLIFERATIVE DISORDERS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

BONE MARROW CELLS; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA, MYELOID; MUTATION; MYELOPROLIFERATIVE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84906226271     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.05.006     Document Type: Article

References (36)

1. J.R. ten Bosch, and W.W. Grody Keeping up with the next generation: massively parallel sequencing in clinical diagnostics J Mol Diagn 10 2008 484 492
2. R. Natrajan, and J.S. Reis-Filho Next-generation sequencing applied to molecular diagnostics Expert Rev Mol Diagn 11 2011 425 444
3. D. Lipson, M. Capelletti, R. Yelensky, G. Otto, A. Parker, M. Jarosz, J.A. Curran, S. Balasubramanian, T. Bloom, K.W. Brennan, A. Donahue, S.R. Downing, G.M. Frampton, L. Garcia, F. Juhn, K.C. Mitchell, E. White, J. White, Z. Zwirko, T. Peretz, H. Nechushtan, L. Soussan-Gutman, J. Kim, H. Sasaki, H.R. Kim, S.I. Park, D. Ercan, C.E. Sheehan, J.S. Ross, M.T. Cronin, P.A. Janne, and P.J. Stephens Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies Nat Med 18 2012 382 384
4. N. Wagle, M.F. Berger, M.J. Davis, B. Blumenstiel, M. Defelice, P. Pochanard, M. Ducar, P. Van Hummelen, L.E. Macconaill, W.C. Hahn, M. Meyerson, S.B. Gabriel, and L.A. Garraway High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing Cancer Discov 2 2012 82 93
5. R.R. Singh, K.P. Patel, M.J. Routbort, N.G. Reddy, B.A. Barkoh, B. Handal, R. Kanagal-Shamanna, W.O. Greaves, L.J. Medeiros, K.D. Aldape, and R. Luthra Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes J Mol Diagn 15 2013 607 622
6. R. Kanagal-Shamanna, B.P. Portier, R.R. Singh, M.J. Routbort, K.D. Aldape, B.A. Handal, H. Rahimi, N.G. Reddy, B.A. Barkoh, B.M. Mishra, A.V. Paladugu, J.H. Manekia, N. Kalhor, S.R. Chowdhuri, G.A. Staerkel, L.J. Medeiros, R. Luthra, and K.P. Patel Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics Mod Pathol 27 2013 314 327
7. M.D. Adams, M.L. Veigl, Z. Wang, N. Molyneux, S. Sun, K. Guda, X. Yu, S.D. Markowitz, and J. Willis Global mutational profiling of formalin-fixed human colon cancers from a pathology archive Mod Pathol 25 2012 1599 1608
8. R. Tewhey, J.B. Warner, M. Nakano, B. Libby, M. Medkova, P.H. David, S.K. Kotsopoulos, M.L. Samuels, J.B. Hutchison, J.W. Larson, E.J. Topol, M.P. Weiner, O. Harismendy, J. Olson, D.R. Link, and K.A. Frazer Microdroplet-based PCR enrichment for large-scale targeted sequencing Nat Biotechnol 27 2009 1025 1031
9. M.A. Sanders, and P.J. Valk The evolving molecular genetic landscape in acute myeloid leukaemia Curr Opin Hematol 20 2013 79 85
10. B.J. Wouters, B. Lowenberg, and R. Delwel A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects Blood 113 2009 291 298
11. M.E. Figueroa, S. Lugthart, Y. Li, C. Erpelinck-Verschueren, X. Deng, P.J. Christos, E. Schifano, J. Booth, W. van Putten, L. Skrabanek, F. Campagne, M. Mazumdar, J.M. Greally, P.J. Valk, B. Lowenberg, R. Delwel, and A. Melnick DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer cell 17 2010 13 27
12. E.R. Mardis, L. Ding, D.J. Dooling, D.E. Larson, M.D. McLellan, and K. Chen et al. Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
13. R.L. Levine, A. Pardanani, A. Tefferi, and D.G. Gilliland Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders Nat Rev Cancer 7 2007 673 683
14. A.D. Pardanani, R.L. Levine, T. Lasho, Y. Pikman, R.A. Mesa, M. Wadleigh, D.P. Steensma, M.A. Elliott, A.P. Wolanskyj, W.J. Hogan, R.F. McClure, M.R. Litzow, D.G. Gilliland, and A. Tefferi MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood 108 2006 3472 3476
15. Y. Pikman, B.H. Lee, T. Mercher, E. McDowell, B.L. Ebert, M. Gozo, A. Cuker, G. Wernig, S. Moore, I. Galinsky, D.J. DeAngelo, J.J. Clark, S.J. Lee, T.R. Golub, M. Wadleigh, D.G. Gilliland, and R.L. Levine MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia PLoS Med 3 2006 e270
16. G. Marcucci, T. Haferlach, and H. Dohner Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications J Clin Oncol 29 2011 475 486
17. R.F. Schlenk, K. Dohner, J. Krauter, S. Frohling, A. Corbacioglu, L. Bullinger, M. Habdank, D. Spath, M. Morgan, A. Benner, B. Schlegelberger, G. Heil, A. Ganser, and H. Dohner Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia N Engl J Med 358 2008 1909 1918
18. M. Cazzola IDH1 and IDH2 mutations in myeloid neoplasms-novel paradigms and clinical implications Haematologica 95 2010 1623 1627
19. A.F. Gombart, W.K. Hofmann, S. Kawano, S. Takeuchi, U. Krug, S.H. Kwok, R.J. Larsen, H. Asou, C.W. Miller, D. Hoelzer, and H.P. Koeffler Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias Blood 99 2002 1332 1340
20. T. Pabst, B.U. Mueller, P. Zhang, H.S. Radomska, S. Narravula, S. Schnittger, G. Behre, W. Hiddemann, and D.G. Tenen Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia Nat Genet 27 2001 263 270
21. B. Falini, I. Nicoletti, M.F. Martelli, and C. Mecucci Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features Blood 109 2007 874 885
22. S. Yokota, H. Kiyoi, M. Nakao, T. Iwai, S. Misawa, T. Okuda, Y. Sonoda, T. Abe, K. Kahsima, Y. Matsuo, and T. Naoe Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines Leukemia 11 1997 1605 1609
23. H. Li, and R. Durbin Fast and accurate short read alignment with Burrows-Wheeler transform Bioinformatics 25 2009 1754 1760
24. A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M.A. DePristo The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 2010 1297 1303
25. K. Cibulskis, M.S. Lawrence, S.L. Carter, A. Sivachenko, D. Jaffe, C. Sougnez, S. Gabriel, M. Meyerson, E.S. Lander, and G. Getz Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples Nat Biotechnol 31 2013 213 219
26. D.C. Koboldt, K. Chen, T. Wylie, D.E. Larson, M.D. McLellan, E.R. Mardis, G.M. Weinstock, R.K. Wilson, and L. Ding VarScan: variant detection in massively parallel sequencing of individual and pooled samples Bioinformatics 25 2009 2283 2285
27. D.C. Koboldt, Q. Zhang, D.E. Larson, D. Shen, M.D. McLellan, L. Lin, C.A. Miller, E.R. Mardis, L. Ding, and R.K. Wilson VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing Genome Res 22 2012 568 576
28. K. Ye, M.H. Schulz, Q. Long, R. Apweiler, and Z. Ning Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads Bioinformatics 25 2009 2865 2871
29. K. Wang, M. Li, and H. Hakonarson ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Res 38 2010 e164
30. S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements, A. Menzies, J.W. Teague, P.A. Futreal, and M.R. Stratton The Catalogue of Somatic Mutations in Cancer (COSMIC) Curr Protoc Hum Genet 2008 Chapter 10:Unit 10 1
31. G.R. Abecasis, A. Auton, L.D. Brooks, M.A. DePristo, R.M. Durbin, R.E. Handsaker, H.M. Kang, G.T. Marth, and G.A. McVean An integrated map of genetic variation from 1,092 human genomes Nature 491 2012 56 65
32. Y. Yamamoto, H. Kiyoi, Y. Nakano, R. Suzuki, Y. Kodera, S. Miyawaki, N. Asou, K. Kuriyama, F. Yagasaki, C. Shimazaki, H. Akiyama, K. Saito, M. Nishimura, T. Motoji, K. Shinagawa, A. Takeshita, H. Saito, R. Ueda, R. Ohno, and T. Naoe Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies Blood 97 2001 2434 2439
33. P.A. Ho, R. Zeng, T.A. Alonzo, R.B. Gerbing, K.L. Miller, J.A. Pollard, D.L. Stirewalt, N.A. Heerema, S.C. Raimondi, B. Hirsch, J.L. Franklin, B. Lange, and S. Meshinchi Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group Blood 116 2010 702 710
34. H.A. Hou, T.C. Huang, L.I. Lin, C.Y. Liu, C.Y. Chen, W.C. Chou, J.L. Tang, M.H. Tseng, C.F. Huang, Y.C. Chiang, F.Y. Lee, M.C. Liu, M. Yao, S.Y. Huang, B.S. Ko, S.C. Hsu, S.J. Wu, W. Tsay, Y.C. Chen, and H.F. Tien WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system Blood 115 2010 5222 5231
35. S. Weissmann, T. Alpermann, V. Grossmann, A. Kowarsch, N. Nadarajah, C. Eder, F. Dicker, A. Fasan, C. Haferlach, T. Haferlach, W. Kern, S. Schnittger, and A. Kohlmann Landscape of TET2 mutations in acute myeloid leukemia Leukemia 26 2012 934 942
36. D.H. Spencer, H.J. Abel, C.M. Lockwood, J.E. Payton, P. Szankasi, T.W. Kelley, S. Kulkarni, J.D. Pfeifer, and E.J. Duncavage Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data J Mol Diagn 15 2013 81 93